EDITORIAL
Editorial comments on this issue of the Journal
Philippe Eigenmann,
Philippe Eigenmann
Editor-in-Chief
Department of Pediatrics, University Hospitals of Geneva, Geneva, Switzerland
Search for more papers by this authorPhilippe Eigenmann,
Philippe Eigenmann
Editor-in-Chief
Department of Pediatrics, University Hospitals of Geneva, Geneva, Switzerland
Search for more papers by this authorFirst published: 29 July 2018
No abstract is available for this article.
REFERENCES
- 1Kidon M, Blanca-Lopez N, Gomez E, et al. Diagnosis and management of hypersensitivity reactions to Non-Steroidal Anti-inflammatory drugs in children and adolescents. Pediatr Allergy Immunol. 2018; 29: 469-480.
- 2Yoshida S, Ide K, Takeuchi M, et al. Prenatal and early-life antibiotic use and risk of childhood asthma: a retrospective cohort study. Pediatr Allergy Immunol. 2018; 29: 490-495.
- 3Carraro S, Bozzetto S, Giordano G, et al. Wheezing preschool children with early-onset asthma reveal a specific metabolomic profile. Pediatr Allergy Immunol. 2018; 29: 375-382.
- 4Chiu C-Y, Lin G, Cheng M-L, et al. Longitudinal urinary metabolomic profiling reveals metabolites for asthma development in early childhood. Pediatr Allergy Immunol. 2018; 29: 496-503.
- 5Melo B, Rezende L, Machado P, et al. Associations of ultra-processed food and drink products with asthma and wheezing among Brazilian adolescents. Pediatr Allergy Immunol. 2018; 29: 504-511.
- 6Schramm D, Reuter M, Grabenhenrich LB, et al. What does lung function tell us about respiratory multimorbidity in childhood and early adulthood? Results from the MAS birth cohort study. Pediatr Allergy Immunol. 2018; 29: 481-489.
- 7Gough H, Grabenhenrich L, Reich A, et al. Allergic multimorbidity of asthma, rhinitis and eczema over 20 years in the German birth cohort MAS. Pediatr Allergy Immunol Off Publ Eur Soc Pediatr Allergy Immunol. 2015; 26: 431-437.
- 8Neuman A, Bergström A, Gustafsson P, et al. Infant wheeze, comorbidities and school age asthma. Pediatr Allergy Immunol. 2014; 25: 380-386.
- 9Hovland V, Riiser A, Mowinckel P, et al. Asthma with allergic comorbidities in adolescence is associated with bronchial responsiveness and airways inflammation. Pediatr Allergy Immunol Off Publ Eur Soc Pediatr Allergy Immunol. 2014; 25: 351-359.
- 10Nachshon L, Goldberg MR, Katz Y, et al. Long-term outcome of peanut oral immunotherapy-Real-life experience. Pediatr Allergy Immunol. 2018; 29: 519-526.
- 11Peters RL, Dang TD, Allen KJ. Specific oral tolerance induction in childhood. Pediatr Allergy Immunol. 2016; 27: 784-794.
- 12Wang J, Sampson HA. Safety and efficacy of epicutaneous immunotherapy for food allergy. Pediatr Allergy Immunol. 2018; 29: 341-349.
- 13Kansen HM, Le T-M, Meijer Y, et al. The impact of oral food challenges for food allergy on quality of life: a systematic review. Pediatr Allergy Immunol. 2018; 29: 527-537.
- 14Venter C, Sommer I, Moonesinghe H, et al. Health-related quality of life in children with perceived and diagnosed food hypersensitivity. Pediatr Allergy Immunol Off Publ Eur Soc Pediatr Allergy Immunol. 2015; 26: 126-132.
- 15van der Valk JPM, Gerth van Wijk R, Flokstra-de Blok BMJ, et al. No difference in health-related quality of life, after a food challenge with cashew nut in children participating in a clinical trial. Pediatr Allergy Immunol. 2016; 27: 812-817.
- 16Nagakura K, Yanagida N, Sato S, et al. Low-dose oral immunotherapy for children with anaphylactic peanut allergy in Japan. Pediatr Allergy Immunol. 2018; 29: 512-518.
- 17Kourosh A, Luna RA, Nance C, et al. Fecal microbiome signatures are different in food allergic children compared to siblings and healthy children. Pediatr Allergy Immunol. 2018; 29: 545-554.
